Liver-Regenerative Transplantation: Regrow and Reset

Area of Science:

• Hepatology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Severe end-stage liver disease necessitates liver transplantation, yet organ availability is a critical limitation.
• The demand for liver transplants is increasing, with only a third of patients on the waiting list receiving transplants.
• Regenerative therapies offer potential solutions by promoting liver tissue repair and regeneration.

Purpose of the Study:

• To review current knowledge on liver repopulation and engineered liver generation.
• To explore the potential of induced pluripotent stem (iPS)-derived liver cells for regenerative therapies.
• To discuss barriers to the clinical implementation of these regenerative approaches.

Main Methods:

• Review of experimental work and current literature on liver regeneration and stem cell-based therapies.
• Analysis of induced pluripotent stem (iPS) cell derivation and application in liver tissue engineering.
• Discussion of challenges in reprogramming liver function and clinical translation.

Main Results:

• Induced pluripotent stem (iPS) cells offer a potential source for unlimited functional liver cells for repopulation and tissue engineering.
• Reprogramming liver cell fate and generating iPS-derived xenogeneic organs are emerging research areas.
• Significant barriers remain for the clinical application of regenerative liver therapies.

Conclusions:

• Regenerative medicine, particularly using iPS-derived cells, holds significant potential to address the organ shortage for liver transplantation.
• Further research is needed to overcome technical and biological hurdles for successful clinical translation.
• Developing strategies for unlimited functional iPS-derived liver cells is crucial for advancing regenerative liver therapies.